4Stephenne X,Foretz M,Taleux N. Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status[J].Diabetologia,2011.3101-3110.
5Viollet B,Andreelli E. AMP-activated protein kinase and metabolic control[J].Handbook of Experimental Pharmacology,2011,(203):303-330.
6Pang M,de la Monte SM,Longato L. PPARdelta agonist attenuates alcohol-induced hepatic insulin resistance and improves liver injury and repair[J].Journal of Hepatology,2009.1192-1201.
7Zhou G,Myers R,Li Y. Role of AMP-activated protein kinase in mechanism of metformin action[J].Journal of Clinical Investigation,2001.1167-1174.
8Hardie DG. AMPK:a key regulator of energy balance in the single cell and the whole organism[J].International Journal of Obesity,2008,(Suppl 4):S7-12.
2Ishizawa M, Mizushige K, Noma T, et al. An antioxidant treatment potentially protects myocardial energy metabolism by regulating uncoupling protein 2 expression in a chronic beta-adrenergic stimulation rat model. Life Sci, 2006, 78: 2974-2782.
3Bragoszewski P, Habior A, Walewska-Zielecka B, et al. Expression of genes encoding mitochondrial proteins can distinguish nonalco- holic steatosis from steatohepatitis. Acta Biochim Pol, 2007, 54: 341-348.
4Fulop P, Derdak Z, Sheets A, et al. Lack of UCP2 reduces Fasmediated liver injury in ob/ob mice and reveals importance of cell- specific UCP2 expression. Hepatology, 2006, 44: 592-601.
6Tipoe GL,Liong EC,Casey,CA,et al.A voluntary oral ethanolfeeding rat model associated with neeroinflammatory liver injury.Alcohol Clin Exp Res,2008,32:669-682.
7Sampey BP,Korourian S,Ronis M J,et al.Immunohistoehemieal characterization of hepatic malondialdehyde and 4-hydroxynonanal modified proteins during early stages of ethanol-induced fiver injury.Alcohol Clin Exp Res,2003,27:1015-1022.
8Basu S.Carbon tetrachloride-induced lipid peroxidation:eicosanoid formation and their regulation by antioxidant nutrients.Toxicology,2003,189:113-127.
9Yu J,Ip E,Dela Pefia A,et al.COX-2 induction in mice with experimental nutritional steatohepatitis:Role as pro-inflammatory mediator.Hepatology,2006,43:826-836.
1You M, Rogers CQ. Adiponectin: a key adipokine in alcoholic fatty liver[J]. Exp Biol Med (Maywood), 2009, 234 (8): 850-859.
2Yin H, Hu M, Zhang R, et al. MicroRNA-217 promotes ethanol- induced fat accumulation in hepatocytes by down-regulating SIRT1 [J]. J Biol Chem, 2012, 287(13): 9817-9826.
3Ajmo JM, Liang X, Rogers CQ, et al. Resveratrol alleviates alcoholic fatty liver in mice[J]. Am J Physiol Gastrointest Liver Physiol, 2008, 295(4): G833- G842.
4Shen Z, Liang X, Rogers CQ, et al. Involvement of adiponectin- S/RTI-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice[J]. Am J Physiol Gastrointest Liver Physiol, 2010, 298(3): G364-G374.
5Rogers CQ, Ajmo JM, You M. Adiponectin and alcoholic fatty liver disease[J]. IUBMB Life, 2008, 60(12): 790-797.
6You M, Considine RV, Leone TC, et al. Role of adiponecfin in the protective action of dietary saturated fat against alcoholic fatty liver in mice[J]. Hepatology, 2005, 42(3): 568-577.
7You M, Cao Q, Liang X, et al. Mammalian sirtuin 1 is involved in the protective action of dietary saturated fat against alcoholic fatty liver in mice[Jl. J Nutr, 2008, 1380): 497-501.
8Garcia-Villafranca J, Guill6n A, Castro J. Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver[J]. Biochimie, 2008, 90(3): 460-466.
9Ji C, Chan C, Kaplowitz N.Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model[J]. J Hepatol, 2006, 45(5): 717-724.
10Hu M, Wang F, Li X, et al. Regulation of hepatic lipin-1 by ethanol: role of AMP-activated protein kinase/sterol regulatory element- binding protein 1 signaling in mice[J]. Hepatology, 2012, 55(2): 437- 446.
